Search Results
Search for other papers by Antonio Gonzalez-Bulnes in
Google Scholar
PubMed
Search for other papers by Susana Astiz in
Google Scholar
PubMed
Search for other papers by Cristina Ovilo in
Google Scholar
PubMed
Search for other papers by Clemente J Lopez-Bote in
Google Scholar
PubMed
Search for other papers by Raul Sanchez-Sanchez in
Google Scholar
PubMed
Search for other papers by Maria L Perez-Solana in
Google Scholar
PubMed
Search for other papers by Laura Torres-Rovira in
Google Scholar
PubMed
Search for other papers by Miriam Ayuso in
Google Scholar
PubMed
Search for other papers by Jorge Gonzalez in
Google Scholar
PubMed
undernutrition or overnutrition induces higher body corpulence and adiposity, development of metabolic syndrome and the prodrome of type-2 diabetes in the first generation of descendants ( Barbero et al . 2013 ). The objective of this study was to determine the
Search for other papers by Renato Simões Gaspar in
Google Scholar
PubMed
Search for other papers by Renata Ohana Alves Benevides in
Google Scholar
PubMed
Search for other papers by João Lucas de Lima Fontelles in
Google Scholar
PubMed
Search for other papers by Caroline Castro Vale in
Google Scholar
PubMed
Search for other papers by Lucas Martins França in
Google Scholar
PubMed
Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
Search for other papers by Paulo de Tarso Silva Barros in
Google Scholar
PubMed
Search for other papers by Antonio Marcus de Andrade Paes in
Google Scholar
PubMed
Introduction Obesity and metabolic syndrome (MetS) have escalating prevalence worldwide and have reached an epidemic proportion, affecting the world population regardless of ethnicity or Human Development Index ( O’Neill & O’Driscoll 2015
Search for other papers by Umberto Simeoni in
Google Scholar
PubMed
Search for other papers by Clive Osmond in
Google Scholar
PubMed
Search for other papers by Ricardo Garay in
Google Scholar
PubMed
Search for other papers by Christophe Buffat in
Google Scholar
PubMed
Search for other papers by Farid Boubred in
Google Scholar
PubMed
Search for other papers by Christophe Chagnaud in
Google Scholar
PubMed
Search for other papers by Elisabeth Jouve in
Google Scholar
PubMed
Search for other papers by Christine Audebert in
Google Scholar
PubMed
Search for other papers by Jean-Michel Antoine in
Google Scholar
PubMed
Search for other papers by Kent Thornburg in
Google Scholar
PubMed
individual to be vulnerable for the metabolic syndrome (T2DM, high plasma triglycerides, low HDL cholesterol and hypertension) ( Barker 2000 ). Low birthweight babies have decreased muscle mass in infancy ( Robinson et al . 1991 ), a condition maintained
Department of Medicine Austin Health, Department of Endocrinology, University of Melbourne, 145 Studley Road, Heidelberg, Victoria 3084, Australia
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
for the large proportion of men with metabolic disorders, defined here as type 2 diabetes and or the metabolic syndrome, but without clear-cut classical hypogonadism, is not known. This is because we have insufficient evidence to conclusively answer
Search for other papers by Hong-Yo Kang in
Google Scholar
PubMed
current knowledge of the metabolic and vascular actions of testosterone in these disorders – specifically, how testosterone deficiency contributes to insulin resistance, metabolic syndrome, type 2 diabetes ( Kelly & Jones 2013 a ), and cardiovascular
Search for other papers by Isabel Huang-Doran in
Google Scholar
PubMed
Search for other papers by Alison Sleigh in
Google Scholar
PubMed
Search for other papers by Justin J Rochford in
Google Scholar
PubMed
Search for other papers by Stephen O'Rahilly in
Google Scholar
PubMed
Search for other papers by David B Savage in
Google Scholar
PubMed
, we briefly summarise the lipodystrophy syndromes, their presentation and their classification, then we review recent work into the causes and effects of lipodystrophy, and how the insights they provide may be applicable to prevalent metabolic disease
Search for other papers by Romy I Kerbus in
Google Scholar
PubMed
Search for other papers by Megan A Inglis in
Google Scholar
PubMed
Search for other papers by Greg M Anderson in
Google Scholar
PubMed
characteristics of the metabolic syndrome in women with polycystic ovary syndrome . Journal of Clinical Endocrinology and Metabolism 90 1929 – 1935 . ( https://doi.org/10.1210/jc.2004-1045 ) Baker BJ Akhtar LN & Benveniste EN 2009 SOCS1 and SOCS3 in the
Search for other papers by Takeshi Iwasa in
Google Scholar
PubMed
Search for other papers by Toshiya Matsuzaki in
Google Scholar
PubMed
Search for other papers by Kiyohito Yano in
Google Scholar
PubMed
Search for other papers by Yiliyasi Mayila in
Google Scholar
PubMed
Search for other papers by Rie Yanagihara in
Google Scholar
PubMed
Search for other papers by Yuri Yamamoto in
Google Scholar
PubMed
Search for other papers by Akira Kuwahara in
Google Scholar
PubMed
Search for other papers by Minoru Irahara in
Google Scholar
PubMed
://doi.org/10.1016/j.mce.2013.01.013 ) Barber TM Wass JA McCarthy MI Franks S 2007 Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhea but normal androgen levels: implications for the management of polycystic ovary syndrome
Search for other papers by Laura D Ratner in
Google Scholar
PubMed
Hospital General de Agudos J. M. Ramos Mejía, Buenos Aires, Argentina
Search for other papers by Guillermina Stevens in
Google Scholar
PubMed
Search for other papers by Maria Marta Bonaventura in
Google Scholar
PubMed
Search for other papers by Victoria A Lux-Lantos in
Google Scholar
PubMed
Turku Center for Disease Modeling, University of Turku, Turku, Finland
Search for other papers by Matti Poutanen in
Google Scholar
PubMed
Search for other papers by Ricardo S Calandra in
Google Scholar
PubMed
Department of Surgery and Cancer, Imperial College London, London, UK
Search for other papers by Ilpo T Huhtaniemi in
Google Scholar
PubMed
Search for other papers by Susana B Rulli in
Google Scholar
PubMed
Introduction Metabolic syndrome is a growing epidemic worldwide that involves 1 out of 4 adult people, and its prevalence increases with age ( Grundy 2008 ). The consensus statement provided by the International Diabetes Federation (IDF
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Susan Kralisch in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Anke Tönjes in
Google Scholar
PubMed
Search for other papers by Kerstin Krause in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Judit Richter in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Ulrike Lossner in
Google Scholar
PubMed
Search for other papers by Peter Kovacs in
Google Scholar
PubMed
Search for other papers by Thomas Ebert in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Matthias Blüher in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Michael Stumvoll in
Google Scholar
PubMed
Medical Department, Leipzig University Medical Center, LIFE Study Center, University of Leipzig, Liebigstrasse 18, 04103 Leipzig, Germany
Search for other papers by Mathias Fasshauer in
Google Scholar
PubMed
and independently correlated with facets of the metabolic syndrome including obesity, insulin resistance, hypertension, and dyslipidemia in nondiabetic subjects. In agreement with this notion, circulating FGF21 is increased in T2DM compared with